Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (29286)
All Articles published online
|
Publishing Process of This Article
|
Nov 14, 2016 (publication date) through Dec 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Billmeier U, Dieterich W, Neurath MF, Atreya R. Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases. World J Gastroenterol 2016; 22(42): 9300-9313 [PMID: 27895418 DOI: 10.3748/wjg.v22.i42.9300] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i42/9300.htm |
| Number | Citing Articles |
| 1 |
Jun-Jang Jin, Il-Gyu Ko, Lakkyong Hwang, Sang-Hoon Kim, Yong-Seok Jee, Hyeon Jeon, Su Bee Park, Jung Won Jeon. Simultaneous Treatment of 5-Aminosalicylic Acid and Treadmill Exercise More Effectively Improves Ulcerative Colitis in Mice. International Journal of Molecular Sciences 2024; 25(10): 5076 doi: 10.3390/ijms25105076
|
| 2 |
Susanna Nikolaus, Georg H. Waetzig, Sven Butzin, Monika Ziolkiewicz, Natalie Al-Massad, Florian Thieme, Ulf Lövgren, Birgitte B. Rasmussen, Torsten M. Reinheimer, Dirk Seegert, Philip Rosenstiel, Silke Szymczak, Stefan Schreiber. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases. International Journal of Colorectal Disease 2018; 33(7): 927 doi: 10.1007/s00384-018-3069-8
|
| 3 |
Lorena Ortega Moreno, Samuel Fernández-Tomé, Raquel Abalo. Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions. Biologics 2021; 1(2): 189 doi: 10.3390/biologics1020012
|
| 4 |
Supriya Roy, Suneela Dhaneshwar, Tarique Mahmood. Exploring the Potential of IL-1β Inhibitor Diacerein and its Combination
with 5-aminosalicylic Acid for the Possible Ameliorating Effect in TNBSinduced
Experimental Colitis in Wistar Rats. Current Drug Therapy 2022; 17(2): 132 doi: 10.2174/1574885517666220328142715
|
| 5 |
Lorenzo Bertani, Luca Antonioli, Matteo Fornai, Gherardo Tapete, Giovanni Baiano Svizzero, Santino Marchi, Corrado Blandizzi, Francesco Costa. Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases. Minerva Gastroenterologica e Dietologica 2020; 65(4) doi: 10.23736/S1121-421X.19.02621-7
|
| 6 |
Renata Curciarello, Guillermo H. Docena, Thomas T. MacDonald. The Role of Cytokines in the Fibrotic Responses in Crohn’s Disease. Frontiers in Medicine 2017; 4 doi: 10.3389/fmed.2017.00126
|
| 7 |
Yulia Liubomirski, Shalom Lerrer, Tsipi Meshel, Dina Morein, Linor Rubinstein-Achiasaf, David Sprinzak, Stefan Wiemann, Cindy Körner, Marcelo Ehrlich, Adit Ben-Baruch. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00804
|
| 8 |
Mayara Santa Rosa Lima, Vanessa Cristina Oliveira de Lima, Grasiela Piuvezam, Kesley Pablo Morais de Azevedo, Bruna Leal Lima Maciel, Ana Heloneida de Araújo Morais. Mechanisms of action of molecules with anti-TNF-alpha activity on intestinal barrier inflammation. Medicine 2019; 98(39): e17285 doi: 10.1097/MD.0000000000017285
|
| 9 |
Ralley E. Prentice, Emily K. Wright, Emma Flanagan, Rod W. Hunt, Gregory T. Moore, Claudia A. Nold-Petry, Sally J. Bell, Marcel F. Nold, Rimma Goldberg. The Effect of In Utero Exposure to Maternal Inflammatory Bowel Disease and Immunomodulators on Infant Immune System Development and Function. Cellular and Molecular Gastroenterology and Hepatology 2023; 16(1): 165 doi: 10.1016/j.jcmgh.2023.03.005
|
| 10 |
Axue Wu, Yuan Gao, Ruotong Kan, Pengfei Ren, Changhu Xue, Biao Kong, Qingjuan Tang. Alginate Oligosaccharides Prevent Dextran-Sulfate-Sodium-Induced Ulcerative Colitis via Enhancing Intestinal Barrier Function and Modulating Gut Microbiota. Foods 2023; 12(1): 220 doi: 10.3390/foods12010220
|
| 11 |
Xuhui Tong, Yuanyuan Zheng, Yu Li, Yongjian Xiong, Dapeng Chen. Soluble ligands as drug targets for treatment of inflammatory bowel disease. Pharmacology & Therapeutics 2021; 226: 107859 doi: 10.1016/j.pharmthera.2021.107859
|
| 12 |
Arushi Kohli, Alan C Moss. Personalizing therapy selection in inflammatory bowel disease. Expert Review of Clinical Immunology 2023; 19(4): 431 doi: 10.1080/1744666X.2023.2185605
|
| 13 |
Zizhen Gong, Shengnan Zhao, Jiefei Zhou, Junkai Yan, Lingyu Wang, Xixi Du, Hui Li, Yingwei Chen, Wei Cai, Jin Wu. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production. Molecular Immunology 2018; 104: 11 doi: 10.1016/j.molimm.2018.09.004
|
| 14 |
Johanna Pott, Agnieszka Martyna Kabat, Kevin Joseph Maloy. Intestinal Epithelial Cell Autophagy Is Required to Protect against TNF-Induced Apoptosis during Chronic Colitis in Mice. Cell Host & Microbe 2018; 23(2): 191 doi: 10.1016/j.chom.2017.12.017
|
| 15 |
Wilbert Bouwman, Wim Verhaegh, Anja van de Stolpe. Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1008976
|
| 16 |
Aleksandra Górecka, Agnieszka Jura-Półtorak, Ewa M. Koźma, Anna Szeremeta, Krystyna Olczyk, Katarzyna Komosińska-Vassev. Biochemical Modulators of Tight Junctions (TJs): Occludin, Claudin-2 and Zonulin as Biomarkers of Intestinal Barrier Leakage in the Diagnosis and Assessment of Inflammatory Bowel Disease Progression. Molecules 2024; 29(19): 4577 doi: 10.3390/molecules29194577
|
| 17 |
Hagar Ben-Yaakov, Tsipi Meshel, Metsada Pasmanik-Chor, Cindy Körner, Adit Ben-Baruch. A Tumor Microenvironment-Driven Network Regulated by STAT3 and p65 Negatively Controls the Enrichment of Cancer Stem Cells in Human HR+/HER2− Breast Cancer. Cancers 2023; 15(8): 2255 doi: 10.3390/cancers15082255
|
| 18 |
Noriko Iwamoto, Kotoko Yokoyama, Megumi Takanashi, Atsushi Yonezawa, Kazuo Matsubara, Takashi Shimada. Application of nSMOL coupled with LC‐MS bioanalysis for monitoring the Fc‐fusion biopharmaceuticals Etanercept and Abatacept in human serum. Pharmacology Research & Perspectives 2018; 6(4) doi: 10.1002/prp2.422
|
| 19 |
Don Husereau, Brian Feagan, Carl Selya-Hammer. Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching. Applied Health Economics and Health Policy 2018; 16(3): 279 doi: 10.1007/s40258-018-0371-0
|
| 20 |
Gisa Tiegs, Andrea K. Horst. TNF in the liver: targeting a central player in inflammation. Seminars in Immunopathology 2022; 44(4): 445 doi: 10.1007/s00281-022-00910-2
|
| 21 |
Marleen Bouhuys, Willem S. Lexmond, Patrick F. van Rheenen. De-Escalation of Anti-Tumor Necrosis Factor Alpha Agents and Reduction in Adverse Effects: A Systematic Review. Biomedicines 2022; 10(5): 1034 doi: 10.3390/biomedicines10051034
|
| 22 |
Federica Gaiani, Bianca Maria Rotoli, Francesca Ferrari, Amelia Barilli, Rossana Visigalli, Maria Clotilde Carra, Gian Luigi de’Angelis, Nicola de’Angelis, Valeria Dall’Asta. Monocytes from infliximab-resistant patients with Crohn’s disease exhibit a disordered cytokine profile. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-68993-1
|
| 23 |
Junichi Ishida, Masakazu Saitoh, Jochen Springer. Single‐nucleotide polymorphisms in cachexia‐related genes: Can they optimize the treatment of cancer cachexia?. Journal of Cachexia, Sarcopenia and Muscle 2017; 8(3): 516 doi: 10.1002/jcsm.12214
|
| 24 |
Dong-mei Yin, Dai Yuan, Rui-jie Sun, Hong-zhi Xu, Shou-yong Hun, Xiao-hui Sui, Ning-ning Shan. Identification of ORM1, vWF, SPARC, and PPBP as immune-related proteins involved in immune thrombocytopenia by quantitative LC-MS/MS. Clinical Proteomics 2023; 20(1) doi: 10.1186/s12014-023-09413-0
|
| 25 |
Thomas Klag, Jan Wehkamp, Eduard Stange. Wirkmechanismen und Wirkung von Biologika und JAK-Inhibitoren bei CED. Gastro-News 2019; 6(1): 26 doi: 10.1007/s15036-019-0482-y
|
| 26 |
Alan C. Moss. Treatment of Inflammatory Bowel Disease with Biologics. 2018; : 1 doi: 10.1007/978-3-319-60276-9_1
|
| 27 |
Vibeke Andersen, Axel Kornerup Hansen, Berit Lilienthal Heitmann. Potential Impact of Diet on Treatment Effect from Anti-TNF Drugs in Inflammatory Bowel Disease. Nutrients 2017; 9(3): 286 doi: 10.3390/nu9030286
|
| 28 |
Kristin K. Jørgensen, Guro L. Goll, Joe Sexton, Nils Bolstad, Inge C. Olsen, Øivind Asak, Ingrid P. Berset, Ingrid M. Blomgren, Katrine Dvergsnes, Jon Florholmen, Svein O. Frigstad, Magne Henriksen, Jon Hagfors, Gert Huppertz-Hauss, Espen A. Haavardsholm, Rolf A. Klaasen, Bjørn Moum, Geir Noraberg, Ulf Prestegård, Jan H. Rydning, Liv Sagatun, Kathrine A. Seeberg, Roald Torp, Cecilia Vold, David J. Warren, Carl M. Ystrøm, Knut E. A. Lundin, Tore Kvien, Jørgen Jahnsen. Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials. BioDrugs 2020; 34(5): 681 doi: 10.1007/s40259-020-00438-7
|
| 29 |
Batia Weiss, Shomron Ben-Horin, Atar Lev, Efrat Broide, Miri Yavzori, Adi Lahat, Uri Kopylov, Orit Picard, Rami Eliakim, Yulia Ron, Irit Avni-Biron, Anat Yerushalmy-Feler, Amit Assa, Raz Somech, Ariella Bar-Gil Shitrit. Immune function in newborns with in-utero exposure to anti-TNFα therapy. Frontiers in Pediatrics 2022; 10 doi: 10.3389/fped.2022.935034
|
| 30 |
Raja Atreya, Markus F. Neurath, Britta Siegmund. Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00517
|
| 31 |
Shiro Nakamura. Advances in Medical Treatment for Crohn's Disease: Focusing on Molecular Targeted Drugs. Nihon Daicho Komonbyo Gakkai Zasshi 2024; 77(10): 501 doi: 10.3862/jcoloproctology.77.501
|
| 32 |
Roberta Figueiroa Souza, Marcos Antônio Ferreira Caetano, Henrique Inhauser Riceti Magalhães, Patricia Castelucci. Study of tumor necrosis factor receptor in the inflammatory bowel disease. World Journal of Gastroenterology 2023; 29(18): 2733-2746 doi: 10.3748/wjg.v29.i18.2733
|
| 33 |
Liliana Lykowska-Szuber, Michal Walczak, Agnieszka Dobrowolska, Marzena Skrzypczak-Zielinska. Apoptosis and inflammatory genes variants in primary non-response to anti-TNF therapy in Crohn’s disease patients. European Journal of Gastroenterology & Hepatology 2023; 35(10): 1088 doi: 10.1097/MEG.0000000000002618
|
| 34 |
Seema Yadav, Narahari Narayan Palei, Subas Chandra Dinda, Arghya Kusum Dhar. Concepts in Pharmaceutical Biotechnology and Drug Development. Interdisciplinary Biotechnological Advances 2024; : 103 doi: 10.1007/978-981-97-1148-2_7
|
| 35 |
HoUng Kim, Rieke Alten, Luisa Avedano, Axel Dignass, Fernando Gomollón, Kay Greveson, Jonas Halfvarson, Peter M. Irving, Jørgen Jahnsen, Péter L. Lakatos, JongHyuk Lee, Souzi Makri, Ben Parker, Laurent Peyrin-Biroulet, Stefan Schreiber, Steven Simoens, Rene Westhovens, Silvio Danese, Ji Hoon Jeong. The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases. Drugs 2020; 80(2): 99 doi: 10.1007/s40265-020-01256-5
|
| 36 |
Na Wu, Xinchong Du, Zhao Peng, Zetian Zhang, Lijun Cui, Duo Li, Rui Wang, Maoyuan Ma. Silencing of peroxiredoxin 1 expression ameliorates ulcerative colitis in a rat model. Journal of International Medical Research 2021; 49(3) doi: 10.1177/0300060520986313
|
| 37 |
Anna Kofla-Dłubacz, Tomasz Pytrus, Katarzyna Akutko, Patrycja Sputa-Grzegrzółka, Aleksandra Piotrowska, Piotr Dzięgiel. Etiology of IBD—Is It Still a Mystery?. International Journal of Molecular Sciences 2022; 23(20): 12445 doi: 10.3390/ijms232012445
|
| 38 |
Shima Hasanzadeh, Morgayn I. Read, Abigail R. Bland, Muhammed Majeed, Tannaz Jamialahmadi, Amirhossein Sahebkar. Curcumin: an inflammasome silencer. Pharmacological Research 2020; 159: 104921 doi: 10.1016/j.phrs.2020.104921
|
| 39 |
Qiuling Lin, Dingguo Zhang, Jian Zhang, Weixiang Luo, Zhenglei Xu, Jun Yao, Lisheng Wang. Identification of lncRNA DLEU2 as a potential diagnostic biomarker and anti-inflammatory target for ulcerative colitis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.991448
|
| 40 |
Francesca Penagini, Luisa Lonoce, Luisa Abbattista, Valentina Silvera, Giulia Rendo, Lucia Cococcioni, Dario Dilillo, Valeria Calcaterra, Gian Vincenzo Zuccotti. Dual biological therapy and small molecules in pediatric inflammatory bowel disease. Pharmacological Research 2023; 196: 106935 doi: 10.1016/j.phrs.2023.106935
|
| 41 |
Jill L. Kinzer, Troy A. Halseth, Jukyung Kang, Sang Yeop Kim, Preethi Kumaran, Michael Ford, Sergei Saveliev, St John Skilton, Anna Schwendeman. Physicochemical characterization and functionality comparison of Humira®(adalimumab), Remicade®(infliximab) and Simponi Aria® (golimumab). International Journal of Pharmaceutics 2023; 635: 122646 doi: 10.1016/j.ijpharm.2023.122646
|
| 42 |
Agata Michalak, Beata Kasztelan-Szczerbinska, Katarzyna Laskowska, Piotr Radwan, Marek Cybulski, Halina Cichoż-Lach. Efficacy of biological treatment in inflammatory bowel disease – a single-center experience. Polish Journal of Public Health 2019; 129(3): 105 doi: 10.2478/pjph-2019-0024
|
| 43 |
Joel V. Chua, John W. Baddley. Infectious Complications in Biologic and Targeted Therapies. 2022; : 69 doi: 10.1007/978-3-031-11363-5_5
|
| 44 |
Ladan Agharokh, Katherine Mamola, Andrew G. Yu, Annette L. Medina, Bhaskar Gurram, Julie Fuller, Jason Y. Park, Weina Chen, Veena Rajaram, Matthew R. Hammer, Jeff L. Waugh. Cachexia, chorea, and pain in chronic nonbacterial osteitis and inflammatory bowel disease: a case report. Journal of Medical Case Reports 2023; 17(1) doi: 10.1186/s13256-023-03894-1
|
| 45 |
Sudha B. Singh, Cody A. Braun, Amanda Carroll-Portillo, Cristina N. Coffman, Henry C. Lin. Sulfate-Reducing Bacteria Induce Pro-Inflammatory TNF-α and iNOS via PI3K/Akt Pathway in a TLR 2-Dependent Manner. Microorganisms 2024; 12(9): 1833 doi: 10.3390/microorganisms12091833
|
| 46 |
Yuki Ozato, Tomoaki Hara, Sikun Meng, Hiromichi Sato, Shotaro Tatekawa, Mamoru Uemura, Takeshi Yabumoto, Shizuka Uchida, Kazuhiko Ogawa, Yuichiro Doki, Hidetoshi Eguchi, Hideshi Ishii. RNA methylation in inflammatory bowel disease. Cancer Science 2024; 115(3): 723 doi: 10.1111/cas.16048
|
| 47 |
Raja Atreya, Markus F Neurath. IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality. Journal of Crohn's and Colitis 2022; 16(Supplement_2): ii54 doi: 10.1093/ecco-jcc/jjac007
|
| 48 |
Federica Crispino, Mauro Grova, Erica Maria Bruno, Noemi Monachino, Giuseppe Rizzo, Angelo Casà, Sara Renna, Fabio Salvatore Macaluso, Ambrogio Orlando. Spondyloarthropathy in Inflammatory Bowel Disease: From Pathophysiology to Pharmacological Targets. Drugs 2022; 82(11): 1151 doi: 10.1007/s40265-022-01750-y
|
| 49 |
Asma Boumaza, Soraya Mezouar, Matthieu Bardou, Didier Raoult, Jean-Louis Mège, Benoit Desnues. Tumor Necrosis Factor Inhibitors Exacerbate Whipple’s Disease by Reprogramming Macrophage and Inducing Apoptosis. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.667357
|
| 50 |
Ling Zhang, Yihang Zhang, Jihong Pan. Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs. Intractable & Rare Diseases Research 2021; 10(3): 154 doi: 10.5582/irdr.2021.01022
|
| 51 |
Jinshun Zhu, Huan Yu, Longzhi Xie, Dujuan Shuai, Zhixian Huang, Yufei Chen, Chao Ni, Chang Jia, Xing Rong, Lifang Zhang, Maoping Chu. A novel format of TNF-α binding affibody molecule ameliorate coronary artery endothelial injury in a mouse model of Kawasaki disease. International Journal of Biological Macromolecules 2024; 281: 136255 doi: 10.1016/j.ijbiomac.2024.136255
|
| 52 |
Yue Zeng, Xingyu Liu, Qing Yi, Gan Qiao, Lulu Wang, Li Chen, Ling Fan, Yao Li, Lingjing Duan, Liqiang Huang, Qian Zhuang, Yejiang Zhou, Yuxia Xiong. Free total rhubarb anthraquinones protect intestinal mucosal barrier of SAP rats via inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway. Journal of Ethnopharmacology 2024; 326: 117873 doi: 10.1016/j.jep.2024.117873
|
| 53 |
Yaoyao Du, Lan Rong, Yuanhua Cong, Lan Shen, Ning Zhang, Bing Wang. Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease. Expert Opinion on Therapeutic Targets 2021; 25(3): 191 doi: 10.1080/14728222.2021.1901079
|
| 54 |
Talal S. Alharbi, Ziyad S. Alshammari, Ziyad N. Alanzi, Fahad Althobaiti, Mohammed A. F. Elewa, Khalid S. Hashem, Mohammed M. H. Al-Gayyar. Therapeutic effects of genistein in experimentally induced ulcerative colitis in rats via affecting mitochondrial biogenesis. Molecular and Cellular Biochemistry 2024; 479(2): 431 doi: 10.1007/s11010-023-04746-8
|
| 55 |
Dan Pu, Zhe Zhang, Baisui Feng. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.906419
|
| 56 |
Tamir Baram, Nino Oren, Nofar Erlichman, Tsipi Meshel, Adit Ben-Baruch. Inflammation-Driven Regulation of PD-L1 and PD-L2, and Their Cross-Interactions with Protective Soluble TNFα Receptors in Human Triple-Negative Breast Cancer. Cancers 2022; 14(14): 3513 doi: 10.3390/cancers14143513
|
| 57 |
Florence Hoogewoud, Laura Kowalczuk, Elodie Bousquet, Antoine Brézin, Elodie Touchard, Ronald Buggage, Thierry Bordet, Francine Behar-Cohen. Les anti-TNF-α pour le traitement des uvéites non infectieuses. médecine/sciences 2020; 36(10): 893 doi: 10.1051/medsci/2020160
|
| 58 |
Meng‐Tzu Weng, Chia‐Yueh Hsiung, Shu‐Chen Wei, Yunching Chen. Nanotechnology for Targeted Inflammatory Bowel Disease Therapy: Challenges and Opportunities. WIREs Nanomedicine and Nanobiotechnology 2024; 16(5) doi: 10.1002/wnan.1999
|
| 59 |
Rosanne W Meijboom, Liese Barbier, Louise C Druedahl, Kati Sarnola, Hanna M Tolonen, Helga Gardarsdottir, Toine C G Egberts, Thijs J Giezen. Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance. Expert Opinion on Biological Therapy 2023; 23(8): 801 doi: 10.1080/14712598.2023.2189008
|
| 60 |
Patricia Mae Garcia, Jeff Moore, David Kahan, Mee Young Hong. Effects of Vitamin D Supplementation on Inflammation, Colonic Cell Kinetics, and Microbiota in Colitis: A Review. Molecules 2020; 25(10): 2300 doi: 10.3390/molecules25102300
|
| 61 |
Shyi-Jou Chen, Gu-Jiun Lin, Jing-Wun Chen, Kai-Chen Wang, Chiung-Hsi Tien, Chih-Fen Hu, Chia-Ning Chang, Wan-Fu Hsu, Hueng-Chuen Fan, Huey-Kang Sytwu. Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis. International Journal of Molecular Sciences 2019; 20(6): 1332 doi: 10.3390/ijms20061332
|
| 62 |
Barbara Ruder, Raja Atreya, Christoph Becker. Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases. International Journal of Molecular Sciences 2019; 20(8): 1887 doi: 10.3390/ijms20081887
|
| 63 |
H.B. Costa-Filho, T.M.A.L. Sales, S.M. Paula, L.A.D. Nicolau, M.L. Queiroga, A. Havt, P.M.G. Soares, A.L.R. Barbosa, M.H.L.P. Souza. Role of cyclooxygenases 1 and 2 in the maintenance of colonic mucosal integrity in an experimental colitis model. Brazilian Journal of Medical and Biological Research 2023; 56 doi: 10.1590/1414-431x2023e12946
|
| 64 |
J.W. Baddley, F. Cantini, D. Goletti, J.J. Gómez-Reino, E. Mylonakis, R. San-Juan, M. Fernández-Ruiz, J. Torre-Cisneros. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents). Clinical Microbiology and Infection 2018; 24: S10 doi: 10.1016/j.cmi.2017.12.025
|
| 65 |
Sung-Eun Kim, Il-Gyu Ko, Jun-Jang Jin, Lakkyong Hwang, Chang-Ju Kim, Sang-Hoon Kim, Jin-Hee Han, Jung Won Jeon. Polydeoxyribonucleotide Exerts Therapeutic Effect by Increasing VEGF and Inhibiting Inflammatory Cytokines in Ischemic Colitis Rats. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/2169083
|
| 66 |
Chuan Zhang, Huiping Zhu, Hui Jie, Hengyue Ding, Hongwen Sun. Arbutin ameliorated ulcerative colitis of mice induced by dextran sodium sulfate (DSS). Bioengineered 2021; 12(2): 11707 doi: 10.1080/21655979.2021.2005746
|
| 67 |
E. A. Belousova, I. G. Kozlov, D. I. Abdulganieva, O. P. Alexeeva, I. V. Gubonina, A. A. Lishchinskaya, L. V. Tarasova, E. Yu. Chashkova, M. V. Shapina, O. S. Shifrin, O. B. Shchukina. Immunological aspects of determination of an adequate biological treatment sequence for inflammatory bowel diseases: the expert board statement (St. Petersburg, May 22, 2021). Almanac of Clinical Medicine 2021; 49(7): 485 doi: 10.18786/2072-0505-2021-49-060
|
| 68 |
Annalisa Di Rienzo, Lisa Marinelli, Marilisa Pia Dimmito, Eleonora Chiara Toto, Antonio Di Stefano, Ivana Cacciatore. Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems. Pharmaceutics 2024; 16(9): 1185 doi: 10.3390/pharmaceutics16091185
|
| 69 |
M. Eugenia Delgado, Thomas Brunner. The many faces of tumor necrosis factor signaling in the intestinal epithelium. Genes & Immunity 2019; 20(8): 609 doi: 10.1038/s41435-019-0057-0
|
| 70 |
Vu Q. Nguyen, Kristin Eden, Holly A. Morrison, Megan B. Sammons, Kristin K. Knight, Siena Sorrentino, Rebecca M. Brock, Douglas J. Grider, Irving C. Allen, Dario Sorrentino. Noncanonical NF-κB Signaling Upregulation in Inflammatory Bowel Disease Patients is Associated With Loss of Response to Anti-TNF Agents. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.655887
|
| 71 |
Marwa Ben-Khemis, Dan Liu, Coralie Pintard, Zhuoyao Song, Margarita Hurtado-Nedelec, Jean-Claude Marie, Jamel El-Benna, Pham My-Chan Dang. TNFα counteracts interleukin-10 anti-inflammatory pathway through the NOX2-Lyn-SHP-1 axis in human monocytes. Redox Biology 2023; 67: 102898 doi: 10.1016/j.redox.2023.102898
|
| 72 |
Xiaolin Ye, Jie Wu, Jing Li, Hongyu Wang, Hon W. Koon. Anterior Gradient Protein 2 Promotes Mucosal Repair in Pediatric Ulcerative Colitis. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6483860
|
| 73 |
María Chaparro, Adrià Aterido, Iván Guerra, Marisa Iborra, Jose Luis Cabriada, Luis Bujanda, Carlos Taxonera, Valle García-Sánchez, Ignacio Marín-Jiménez, Manuel Barreiro-de Acosta, Isabel Vera, Maria Dolores Martín-Arranz, Borja Hernández-Breijo, Francisco Mesonero, Laura Sempere, Fernando Gomollón, Joaquín Hinojosa, Fernando Bermejo, Belén Beltrán, Ainhoa Rodríguez-Pescador, Jesús María Banales, David Olivares, Patricia Aguilar-Melero, Luis Menchén, Rocío Ferreiro-Iglesias, Isabel Blazquez Gómez, Beatriz Benitez García, Luis G Guijarro, Alicia C Marin, David Bernardo, Sara Marsal, Antonio Julia, Javier P Gisbert. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819867848
|
| 74 |
Manuel Sutter, Petr Hruz, Jan Hendrik Niess. High Serum Creatine Kinase Levels in Infliximab and Vedolizumab-Treated Inflammatory Bowel Disease Patients. Inflammatory Intestinal Diseases 2021; 6(3): 165 doi: 10.1159/000518264
|
| 75 |
Iuliana Samoilă, Sorina Dinescu, Marieta Costache. Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development—A Focus on Ulcerative Colitis. Cells 2020; 9(7): 1647 doi: 10.3390/cells9071647
|
| 76 |
Markus Ries, Brice Moulari, Maryam A. Shetab Boushehri, Mohamed Ehab Ali, Daniel Molnar, Arnaud Béduneau, Yann Pellequer, Alf Lamprecht. Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting. Pharmaceutics 2022; 14(2): 352 doi: 10.3390/pharmaceutics14020352
|
| 77 |
Hung Hiep Huynh, Naoki Morita, Toshihiro Sakamoto, Takuya Katayama, Takuya Miyakawa, Masaru Tanokura, Yasunori Chiba, Reiko Shinkura, Jun-ichi Maruyama. Functional production of human antibody by the filamentous fungus Aspergillus oryzae. Fungal Biology and Biotechnology 2020; 7(1) doi: 10.1186/s40694-020-00098-w
|
| 78 |
Mai Murakami, Michio Onizawa, Naoto Abe, Tomoaki Mochimaru, Chikako Saito, Rie Hikichi, Takefumi Uemura, Masayuki Sekimata, Hiromasa Ohira. N-glycosylation negatively regulates the expression of tumor necrosis factor (TNF) in mouse macrophage. Biochemical and Biophysical Research Communications 2024; 737: 150897 doi: 10.1016/j.bbrc.2024.150897
|
| 79 |
Shijin Wu, Yuyang Zhou. Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review. Therapeutic Advances in Psychopharmacology 2024; 14 doi: 10.1177/20451253241227772
|
| 80 |
Emanual Maverakis, Angelo V. Marzano, Stephanie T. Le, Jeffrey P. Callen, Marie-Charlotte Brüggen, Emmanuella Guenova, Joachim Dissemond, Kanade Shinkai, Sinéad M. Langan. Pyoderma gangrenosum. Nature Reviews Disease Primers 2020; 6(1) doi: 10.1038/s41572-020-0213-x
|
| 81 |
Linor Rubinstein-Achiasaf, Dina Morein, Hagar Ben-Yaakov, Yulia Liubomirski, Tsipi Meshel, Eti Elbaz, Orly Dorot, Edward Pichinuk, Michael Gershovits, Miguel Weil, Adit Ben-Baruch. Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells. Cancers 2021; 13(6): 1472 doi: 10.3390/cancers13061472
|
| 82 |
Zhaofeng Tan, Haibin Xue, Yuli Sun, Chuanlong Zhang, Yonglei Song, Yuanfu Qi. The Role of Tumor Inflammatory Microenvironment in Lung Cancer. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.688625
|
| 83 |
Raffaella Franca, Debora Curci, Marianna Lucafò, Giuliana Decorti, Gabriele Stocco. Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 2019; 15(7): 527 doi: 10.1080/17425255.2019.1630378
|
| 84 |
Laurence Chapuy, Marwa Bsat, Siranush Sarkizova, Manuel Rubio, Amélie Therrien, Evelyne Wassef, Mickael Bouin, Katarzina Orlicka, Audrey Weber, Nir Hacohen, Alexandra-Chloé Villani, Marika Sarfati. Two distinct colonic CD14+ subsets characterized by single-cell RNA profiling in Crohn's disease. Mucosal Immunology 2019; 12(3): 703 doi: 10.1038/s41385-018-0126-0
|
| 85 |
Tamara Ortiz, Federico Argüelles-Arias, Matilde Illanes, Josefa-María García-Montes, Elena Talero, Laura Macías-García, Ana Alcudia, Victoria Vázquez-Román, Virginia Motilva, Manuel De-Miguel. Polyphenolic Maqui Extract as a Potential Nutraceutical to Treat TNBS-Induced Crohn’s Disease by the Regulation of Antioxidant and Anti-Inflammatory Pathways. Nutrients 2020; 12(6): 1752 doi: 10.3390/nu12061752
|
| 86 |
Beate Beyer, Nicole Walch, Alois Jungbauer, Nico Lingg. How Similar Is Biosimilar? A Comparison of Infliximab Therapeutics in Regard to Charge Variant Profile and Antigen Binding Affinity. Biotechnology Journal 2019; 14(4) doi: 10.1002/biot.201800340
|
| 87 |
Michal Walczak, Liliana Lykowska-Szuber, Marianna Plucinska, Kamila Stawczyk-Eder, Oliwia Zakerska-Banaszak, Piotr Eder, Iwona Krela-Kazmierczak, Michal Michalak, Marek Zywicki, Wojciech M. Karlowski, Marlena Szalata, Agnieszka Dobrowolska, Ryszard Slomski, Marzena Skrzypczak-Zielinska. Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01207
|
| 88 |
Lamiaa A. Hassan, Medhat A. Al‐Ghobashy, Samah S. Abbas. Evaluation of the pattern and kinetics of degradation of adalimumab using a stability‐indicating orthogonal testing protocol. Biomedical Chromatography 2019; 33(12) doi: 10.1002/bmc.4676
|
| 89 |
Meenu Wadhwa, Chris Bird, Eleanor Atkinson, Isabelle Cludts, Peter Rigsby. The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.636420
|
| 90 |
Siyi Ni, Yingchao Liu, Jihong Zhong, Yan Shen. Identification and immunoinfiltration analysis of key genes in ulcerative colitis using WGCNA. PeerJ 2024; 12: e16921 doi: 10.7717/peerj.16921
|
| 91 |
Marcella Gabrielle Mendes Machado, Cauê Benito Scarim, Cleverton Roberto de Andrade, Jean Leandro dos Santos, Chung Man Chin. Synthesis and anti-inflammatory intestinal activity of new glucocorticoid derivatives. Medicinal Chemistry Research 2020; 29(2): 206 doi: 10.1007/s00044-019-02474-7
|
| 92 |
Walter Reinisch, Stanley Cohen, Monica Ramchandani, Majed Khraishi, Jennifer Liu, Vincent Chow, Janet Franklin, Jean-Frederic Colombel. A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar. Advances in Therapy 2022; 39(1): 44 doi: 10.1007/s12325-021-01944-y
|
| 93 |
Stephan Blüml. Biologika und „small molecules“ bei der rheumatoiden Arthritis. Zeitschrift für Rheumatologie 2020; 79(3): 223 doi: 10.1007/s00393-020-00766-7
|
| 94 |
Olivier Lortholary, Mario Fernandez-Ruiz, John W Baddley, Oriol Manuel, Xavier Mariette, Kevin L Winthrop. Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020. Annals of the Rheumatic Diseases 2020; 79(12): 1532 doi: 10.1136/annrheumdis-2020-217092
|
| 95 |
Ramsey Saleem, Greg Cantin, Mats Wikström, Glen Bolton, Scott Kuhns, Helen J. McBride, Jennifer Liu. Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product. Pharmaceutical Research 2020; 37(6) doi: 10.1007/s11095-020-02816-w
|
| 96 |
Alexandra S. Rasiuk, Scott R. Walsh, Lily Chan, Alicia M. Viloria-Petit, Sarah K. Wootton, Khalil Karimi, Byram W. Bridle. The Role of Type I Interferon Signaling in Regulating Cytokine Production and Cell Survival in Bone Marrow-Derived Macrophages. Viral Immunology 2021; 34(7): 470 doi: 10.1089/vim.2020.0308
|
| 97 |
E Antiga, R Maglie, W Volpi, B Bianchi, E Berti, A V Marzano, M Caproni. T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum. Clinical and Experimental Immunology 2017; 189(3): 383 doi: 10.1111/cei.12989
|
| 98 |
Junsuke Uwada, Takashi Yazawa, Md Tariqul Islam, Md Rafiqul Islam Khan, Susanne M. Krug, Michael Fromm, Shin-ichiro Karaki, Yuichi Suzuki, Atsukazu Kuwahara, Hatsumi Yoshiki, Kiyonao Sada, Ikunobu Muramatsu, Takanobu Taniguchi. Activation of muscarinic receptors prevents TNF-α-mediated intestinal epithelial barrier disruption through p38 MAPK. Cellular Signalling 2017; 35: 188 doi: 10.1016/j.cellsig.2017.04.007
|
| 99 |
Shengjie Ma, Jiaxin Zhang, Heshi Liu, Shuang Li, Quan Wang. The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.896591
|
| 100 |
Jerry Z. Xu, Ramesh Kumar, Haoli Gong, Luyao Liu, Nicole Ramos-Solis, Yujing Li, Wilbert A. Derbigny, Craig R. Roy. Toll-Like Receptor 3 Deficiency Leads to Altered Immune Responses to Chlamydia trachomatis Infection in Human Oviduct Epithelial Cells. Infection and Immunity 2019; 87(10) doi: 10.1128/IAI.00483-19
|
| 101 |
Baohai Liu, Xuehua Piao, Lianyi Guo, Guijun Wang, Weihua Sun, Leming Gao, Xuefeng Zheng, Yanli Fang, Steve Harakeh. A New Chinese Medicine Intestine Formula Greatly Improves the Effect of Aminosalicylate on Ulcerative Colitis. Evidence-Based Complementary and Alternative Medicine 2017; 2017(1) doi: 10.1155/2017/7323129
|
| 102 |
Katia Aquilano, Veronica Ceci, Angelo Gismondi, Susanna De Stefano, Federico Iacovelli, Raffaella Faraonio, Gabriele Di Marco, Noemi Poerio, Antonella Minutolo, Giuseppina Minopoli, Antonia Marcone, Maurizio Fraziano, Flavia Tortolici, Simona Sennato, Stefano Casciardi, Marina Potestà, Roberta Bernardini, Maurizio Mattei, Mattia Falconi, Carla Montesano, Stefano Rufini, Antonella Canini, Daniele Lettieri-Barbato. Adipocyte metabolism is improved by TNF receptor-targeting small RNAs identified from dried nuts. Communications Biology 2019; 2(1) doi: 10.1038/s42003-019-0563-7
|
| 103 |
Songmao Zheng, Jin Niu, Brian Geist, Damien Fink, Zhenhua Xu, Honghui Zhou, Weirong Wang. A minimal physiologically based pharmacokinetic model to characterize colon TNF suppression and treatment effects of an anti-TNF monoclonal antibody in a mouse inflammatory bowel disease model. mAbs 2020; 12(1) doi: 10.1080/19420862.2020.1813962
|
| 104 |
Rachel K. Lim, Dina A. Fisher, Stephen K. Field. Tuberculosis. Integrated Science 2023; 11: 697 doi: 10.1007/978-3-031-15955-8_32
|
| 105 |
Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, Mariko Kobayashi, Toshifumi Hibi. Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study. Intestinal Research 2021; 19(4): 419 doi: 10.5217/ir.2020.00033
|
| 106 |
Chang-Cyuan Chen, Yu-An Lin, Kuan-Ting Liu, Chun-Yao Huang, Chun-Ming Shih, Yuan-Ti Lee, Jun-Liang Pan, Ai-Wei Lee. Navigating SARS-CoV-2-related immunopathology in Crohn’s disease: from molecular mechanisms to therapeutic challenges. Virology Journal 2024; 21(1) doi: 10.1186/s12985-024-02529-1
|
| 107 |
Maria S Simon, Gara Arteaga-Henríquez, Ahmed Fouad Algendy, Timo Siepmann, Ben MW Illigens. Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses. Neuropsychiatric Disease and Treatment 2023; : 1 doi: 10.2147/NDT.S385117
|
| 108 |
J. Scott Crowe, Kevin J. Roberts, Timothy M. Carlton, Luana Maggiore, Marion F. Cubitt, Simon Clare, Katherine Harcourt, Jill Reckless, Thomas T. MacDonald, Keith P. Ray, Anna Vossenkämper, Michael R. West. Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-23277-7
|
| 109 |
Gregor Jezernik, Mario Gorenjak, Uroš Potočnik. MIF Variant rs755622 Is Associated with Severe Crohn’s Disease and Better Response to Anti-TNF Adalimumab Therapy. Genes 2023; 14(2): 452 doi: 10.3390/genes14020452
|
| 110 |
Tamir Baram, Linor Rubinstein-Achiasaf, Hagar Ben-Yaakov, Adit Ben-Baruch. Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.614468
|
| 111 |
Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli, Khazna Alotaibi, Abdullah Alsahli, Hussain Mohammad, Preethi Cherian, Irina Al-Khairi, Thangavel Alphonse Thanaraj, Arshad Channanath, Hamad Ali, Mohamed Abu-Farha, Jehad Abubaker, Fahd Al-Mulla. Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies. Vaccines 2021; 9(12): 1471 doi: 10.3390/vaccines9121471
|
| 112 |
Hong‐Gang Wang, Min‐Na Zhang, Xin Wen, Le He, Meng‐Hui Zhang, Jia‐Ling Zhang, Xiao‐Zhong Yang. Cepharanthine ameliorates dextran sulphate sodium‐induced colitis through modulating gut microbiota. Microbial Biotechnology 2022; 15(8): 2208 doi: 10.1111/1751-7915.14059
|
| 113 |
Ziwen Yuan, Lihong Yang, Xiaosong Zhang, Peng Ji, Yongli Hua, Yanming Wei. Huang-Lian-Jie-Du Decoction Ameliorates Acute Ulcerative Colitis in Mice via Regulating NF-κB and Nrf2 Signaling Pathways and Enhancing Intestinal Barrier Function. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.01354
|
| 114 |
Cong-Qiu Chu. Blocking tumor necrosis factor paved the way for targeted therapeutics in inflammatory diseases. Chinese Medical Journal 2021; 134(21): 2525 doi: 10.1097/CM9.0000000000001846
|
| 115 |
Anna Kofla-Dłubacz, Katarzyna Akutko, Elżbieta Krzesiek, Tatiana Jamer, Joanna Braksator, Paula Grębska, Tomasz Pytrus, Andrzej Stawarski. Selective Forms of Therapy in the Treatment of Inflammatory Bowel Diseases. Journal of Clinical Medicine 2022; 11(4): 994 doi: 10.3390/jcm11040994
|
| 116 |
Renata Curciarello, Toni Sobande, Samantha Jones, Paolo Giuffrida, Antonio Di Sabatino, Guillermo H Docena, Thomas T MacDonald, Klaartje Kok. <p>Human Neutrophil Elastase Proteolytic Activity in Ulcerative Colitis Favors the Loss of Function of Therapeutic Monoclonal Antibodies</p>. Journal of Inflammation Research 2020; : 233 doi: 10.2147/JIR.S234710
|
| 117 |
Hu Zhao, Taohui Ding, Yanglin Chen, Wenbin Yang, Jun Rao, Dan Liu, Bo Yi. Arecoline aggravates acute ulcerative colitis in mice by affecting intestinal microbiota and serum metabolites. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1197922
|
| 118 |
Adam Saleh, Usman Ansari, Shaadi Abughazaleh, Kerri Glassner, Bincy P Abraham. Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician. Biologics: Targets and Therapy 2022; : 67 doi: 10.2147/BTT.S335697
|
| 119 |
Laura Clua‐Ferré, Roger Suau, Irene Vañó‐Segarra, Iris Ginés, Carolina Serena, Josep Manyé. Therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles: A focus on inflammatory bowel disease. Clinical and Translational Medicine 2024; 14(11) doi: 10.1002/ctm2.70075
|
| 120 |
Carl L. Manthey, Beverley A. Moore, Yanqing Chen, Matthew J. Loza, Xiang Yao, Hao Liu, Stanley M. Belkowski, Holly Raymond-Parks, Paul J. Dunford, Francisco Leon, Jennifer E. Towne, Scott E. Plevy, Jörn Karhausen. The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis. PLOS ONE 2019; 14(11): e0223918 doi: 10.1371/journal.pone.0223918
|
| 121 |
Irene Marafini, Silvia Sedda, Vincenzo Dinallo, Giovanni Monteleone. Inflammatory cytokines: from discoveries to therapies in IBD. Expert Opinion on Biological Therapy 2019; 19(11): 1207 doi: 10.1080/14712598.2019.1652267
|
| 122 |
Ramasatyaveni Geesala, Willow Schanz, Mikayla Biggs, Garima Dixit, Joseph Skurski, Prajwal Gurung, David K Meyerholz, David Elliott, Priya D Issuree, Thorsten Maretzky. Loss of RHBDF2 results in an early-onset spontaneous murine colitis. Journal of Leukocyte Biology 2019; 105(4): 767 doi: 10.1002/JLB.4A0718-283RR
|
| 123 |
Sabrina Nicolò, Ilaria Faggiani, Carmela Errico, Ferdinando D’Amico, Tommaso Lorenzo Parigi, Silvio Danese, Federica Ungaro. Translational characterization of immune pathways in inflammatory bowel disease: insights for targeted treatments. Expert Review of Clinical Immunology 2024; : 1 doi: 10.1080/1744666X.2024.2400300
|
| 124 |
Jill Coghlan, Hongliang He, Anna S. Schwendeman. Overview of Humira® Biosimilars: Current European Landscape and Future Implications. Journal of Pharmaceutical Sciences 2021; 110(4): 1572 doi: 10.1016/j.xphs.2021.02.003
|
| 125 |
Silvia L Cruz-Martín-del-Campo, Claudia González-Espinosa, Ana Karen Ruiz-Quiñonez, César Javier Carranza-Aguilar. Tipos de muerte celular y sus implicaciones clínicas. El Residente 2020; 15(3): 97 doi: 10.35366/95960
|
| 126 |
Xinxin Luo, Eduardo J. Villablanca. Type 2 immunity in intestinal homeostasis and inflammatory bowel disease. Biochemical Society Transactions 2021; 49(5): 2371 doi: 10.1042/BST20210535
|
| 127 |
Simona Adesso, Giuseppina Autore, Andrea Quaroni, Ada Popolo, Lorella Severino, Stefania Marzocco. The Food Contaminants Nivalenol and Deoxynivalenol Induce Inflammation in Intestinal Epithelial Cells by Regulating Reactive Oxygen Species Release. Nutrients 2017; 9(12): 1343 doi: 10.3390/nu9121343
|
| 128 |
Parsa S. Haque, Neeraj Kapur, Terrence A. Barrett, Arianne L. Theiss. Mitochondrial function and gastrointestinal diseases. Nature Reviews Gastroenterology & Hepatology 2024; 21(8): 537 doi: 10.1038/s41575-024-00931-2
|
| 129 |
Xianping Li, Mingzhe Wang, Chang Liu, Yuchun Xiao, Mengde Li, Chengjun Ban, Yuanming Huang, Miao Cheng, Liqiong Song, Guoxing Liu, Shan Lu, Chengxiang Wang, Zhihong Ren. Qingfeiyin Decoction Inhibits H1N1 Virus Infection via Modulation of Gut Microbiota and Inflammatory Pathways in a Murine Model. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.874068
|
| 130 |
Rui Han, Li Wang, Zhengang Zhao, Lijun You, Sandra Pedisić, Viktoryia Kulikouskaya, Zhiqi Lin. Polysaccharide from Gracilaria Lemaneiformis prevents colitis in Balb/c mice via enhancing intestinal barrier function and attenuating intestinal inflammation. Food Hydrocolloids 2020; 109: 106048 doi: 10.1016/j.foodhyd.2020.106048
|
| 131 |
Yulia Liubomirski, Adit Ben-Baruch. Notch-Inflammation Networks in Regulation of Breast Cancer Progression. Cells 2020; 9(7): 1576 doi: 10.3390/cells9071576
|
| 132 |
Sophie Steeland, Claude Libert, Roosmarijn E. Vandenbroucke. A New Venue of TNF Targeting. International Journal of Molecular Sciences 2018; 19(5): 1442 doi: 10.3390/ijms19051442
|
| 133 |
Jae Jun Park. Mechanism-based Drug Therapy of Inflammatory Bowel Disease With Special Reference to Rheumatic Disease. Journal of Rheumatic Diseases 2020; 27(3): 128 doi: 10.4078/jrd.2020.27.3.128
|
| 134 |
Jonathan L. Digby-Bell, Raja Atreya, Giovanni Monteleone, Nick Powell. Interrogating host immunity to predict treatment response in inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology 2020; 17(1): 9 doi: 10.1038/s41575-019-0228-5
|
| 135 |
Alexandra Garten Schmitt, Thomas Erwes, Lisa M. Chirch. Inflammatory Bowel Disease. Clinical Gastroenterology 2021; : 137 doi: 10.1007/978-3-030-81780-0_6
|
| 136 |
Robert Pietschner, Timo Rath, Markus F. Neurath, Raja Atreya. Current and Emerging Targeted Therapies for Ulcerative Colitis. Visceral Medicine 2023; 39(2): 46 doi: 10.1159/000530983
|
| 137 |
Junsuke Uwada, Hitomi Nakazawa, Ikunobu Muramatsu, Takayoshi Masuoka, Takashi Yazawa. Role of Muscarinic Acetylcholine Receptors in Intestinal Epithelial Homeostasis: Insights for the Treatment of Inflammatory Bowel Disease. International Journal of Molecular Sciences 2023; 24(7): 6508 doi: 10.3390/ijms24076508
|
| 138 |
Yulia Liubomirski, Shalom Lerrer, Tsipi Meshel, Linor Rubinstein-Achiasaf, Dina Morein, Stefan Wiemann, Cindy Körner, Adit Ben-Baruch. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00757
|
| 139 |
Miles P. Sparrow. Adalimumab in ulcerative colitis – efficacy, safety and optimization in the era of treat-to target. Expert Opinion on Biological Therapy 2017; 17(5): 613 doi: 10.1080/14712598.2017.1309390
|
| 140 |
Suhail Nurbhai, Kevin J. Roberts, Timothy M. Carlton, Luana Maggiore, Marion F. Cubitt, Keith P. Ray, Jill Reckless, Hafeez Mohammed, Peter Irving, Thomas T. MacDonald, Anna Vossenkämper, Michael R. West, Gareth C. Parkes, J. Scott Crowe. Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-50545-x
|
| 141 |
Tong Zhang, Guo‐Yan Liu, Jing‐Long Cao, Yan‐Nan Li, Hui Xue, Hai‐Tao Wu, Cheng‐Hao Jin. Peimine‐induced apoptosis and inhibition of migration by regulating reactive oxygen species‐mediated MAPK/STAT3/NF‐κB and Wnt/β‐catenin signaling pathways in gastric cancer MKN‐45 cells. Drug Development Research 2022; 83(7): 1683 doi: 10.1002/ddr.21987
|
| 142 |
Swati Dobhal, Mukesh Nandave, Vinod Tiwari, Mamta F Singh. Unveiling the potential of Cepharanthine from plant to patient- A comprehensive review of phytochemistry, pharmacology and clinical investigations. Journal of Biologically Active Products from Nature 2024; 14(1): 1 doi: 10.1080/22311866.2024.2312835
|
| 143 |
Jaslin P. James, Boye Schnack Nielsen, Ebbe Langholz, Mikkel Malham, Estrid Høgdall, Lene Buhl Riis. Estimating tissue-specific TNF mRNA levels prior to anti-TNFα treatment may support therapeutic optimisation in IBD patients. Scandinavian Journal of Gastroenterology 2023; 58(11): 1237 doi: 10.1080/00365521.2023.2217313
|
| 144 |
Zejin Liu, Xinli Niu, Junpeng Wang. Naringenin as a natural immunomodulator against T cell-mediated autoimmune diseases: literature review and network-based pharmacology study. Critical Reviews in Food Science and Nutrition 2023; 63(32): 11026 doi: 10.1080/10408398.2022.2092054
|
| 145 |
Virginie Millet, Thomas Gensollen, Michael Maltese, Melanie Serrero, Nathalie Lesavre, Christophe Bourges, Christophe Pitaval, Sophie Cadra, Lionel Chasson, Thien Phong Vu Man, Marion Masse, Juan Jose Martinez-Garcia, Fabrice Tranchida, Laetitia Shintu, Konrad Mostert, Erick Strauss, Patricia Lepage, Mathias Chamaillard, Achille Broggi, Laurent Peyrin-Biroulet, Jean-Charles Grimaud, Philippe Naquet, Franck Galland. Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis. Gut 2023; 72(6): 1115 doi: 10.1136/gutjnl-2021-325792
|
| 146 |
Andrea Picchianti-Diamanti, Maria M. Rosado, Raffaele D’Amelio. Infectious Agents and Inflammation: The Role of Microbiota in Autoimmune Arthritis. Frontiers in Microbiology 2018; 8 doi: 10.3389/fmicb.2017.02696
|
| 147 |
Xiao-Zhi Li, Yun Qiu, Louisa Jeffery, Fen Liu, Rui Feng, Jin-Shen He, Jin-Yu Tan, Zi-Yin Ye, Si-Nan Lin, Subrata Ghosh, Marietta Iacucci, Min-Hu Chen, Ren Mao. Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19. Frontiers in Medicine 2021; 7 doi: 10.3389/fmed.2020.613475
|
| 148 |
Bingran Wang, Jun Shen. NF-κB Inducing Kinase Regulates Intestinal Immunity and Homeostasis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.895636
|
| 149 |
Sang Hoon Lee, Jae Geun Song, Hyo-Kyung Han. Site-selective oral delivery of therapeutic antibodies to the inflamed colon via a folic acid-grafted organic/inorganic hybrid nanocomposite system. Acta Pharmaceutica Sinica B 2022; 12(11): 4249 doi: 10.1016/j.apsb.2022.06.006
|
| 150 |
Marcel Vetter, Markus F. Neurath. Treatment Perspectives in Crohn’s Disease. Digestion 2018; 98(3): 135 doi: 10.1159/000488449
|
| 151 |
Lieven Pouillon, Johan Van Stappen, Peter Bossuyt, Silvio Danese, Laurent Peyrin-Biroulet. Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?. Best Practice & Research Clinical Gastroenterology 2018; : 17 doi: 10.1016/j.bpg.2018.05.006
|
| 152 |
Jessica Codesido, Lara García-Varela, Xurxo García-Otero, Sheila Bouzón-Barreiro, Noemí Gómez-Lado, Francisco José Toja-Camba, Cristina Mondelo-García, Héctor Lazaré, Julia Baguña Torres, Jana Vidal-Otero, Santiago Medin-Aguerre, Alejandro Sanchez-Crespo, Francisco J. Otero-Espinar, José R. Herance, Anxo Fernández-Ferreiro, Pablo Aguiar. PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model. International Journal of Pharmaceutics 2025; 669: 125011 doi: 10.1016/j.ijpharm.2024.125011
|
| 153 |
Rishabh Hirawat, Mohd Aslam Saifi, Chandraiah Godugu. Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications. Life Sciences 2021; 267: 118923 doi: 10.1016/j.lfs.2020.118923
|
| 154 |
Marianna Lucafò, Raffaella Franca, Davide Selvestrel, Debora Curci, Letizia Pugnetti, Giuliana Decorti, Gabriele Stocco. Pharmacogenetics of treatments for inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(12): 1209 doi: 10.1080/17425255.2018.1551876
|
| 155 |
Beatriz del Rio, Begoña Redruello, Maria Fernandez, M. Cruz Martin, Victor Ladero, Miguel A. Alvarez. Lactic Acid Bacteria as a Live Delivery System for the in situ Production of Nanobodies in the Human Gastrointestinal Tract. Frontiers in Microbiology 2019; 9 doi: 10.3389/fmicb.2018.03179
|
| 156 |
Daisuke Tateiwa, Hideki Yoshikawa, Takashi Kaito. Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review. Cells 2019; 8(8): 818 doi: 10.3390/cells8080818
|
| 157 |
Irene Soleto, Samuel Fernández-Tomé, Irene Mora-Gutiérrez, Montserrat Baldan-Martin, Cristina Ramírez, Cecilio Santander, José Andrés Moreno-Monteagudo, María José Casanova, Fernando Casals, Sergio Casabona, Irene Becerro, María Chaparro, David Bernardo, Javier P. Gisbert. Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel Disease. Biomedicines 2022; 10(8): 1885 doi: 10.3390/biomedicines10081885
|
| 158 |
Soojung Hahn, Gyuri Kim, Sang-Man Jin, Jae Hyeon Kim. Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model. Biochemical and Biophysical Research Communications 2024; 690: 149291 doi: 10.1016/j.bbrc.2023.149291
|
| 159 |
Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, Kanami Sugimoto, Yuya Imai, Seiji Yokoyama, Yasuo Suzuki. Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance. Intestinal Research 2022; 20(3): 329 doi: 10.5217/ir.2021.00032
|
| 160 |
Lili Hu, Handan Tan, Qingfeng Cao, Gangxiang Yuan, Changwei Huang, Guannan Su, Aize Kijlstra, Peizeng Yang. Weak association of a TNFRSF1A polymorphism with Behcet's disease in Chinese Han. Experimental Eye Research 2020; 196: 108045 doi: 10.1016/j.exer.2020.108045
|
| 161 |
Hannah Schneider, Evelin Berger, Brendan Dolan, Beatriz Martinez-Abad, Liisa Arike, Thaher Pelaseyed, Gunnar C. Hansson. The human transmembrane mucin MUC17 responds to TNFα by increased presentation at the plasma membrane. Biochemical Journal 2019; 476(16): 2281 doi: 10.1042/BCJ20190180
|